Pituitary Tissue Cell Mass Formation in Feeder-Free 3D Suspension
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing pituitary tissue from pluripotent stem cells are inefficient and costly, and fail to replicate the complex three-dimensional structure necessary for functional pituitary tissue, particularly when using feeder-free cultures and reducing the use of expensive recombinant proteins.
Innovation Solution
A method involving suspension culture of pluripotent stem cells with specific signaling pathway modulators, including Wnt and BMP signal transduction pathway activators, and optimizing the timing and concentration of BMP addition, to efficiently produce high-quality pituitary tissue.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Shape
If conventional two-dimensional culture methods are used to produce pituitary cells, then the production process is simple, but the complex three-dimensional structure of pituitary tissue is not reproduced
Solution Approach 1:
The patent transitions from two-dimensional culture to three-dimensional suspension culture by forming cell aggregates that self-organize into spheroidal structures. This dimensional change enables the reproduction of complex pituitary tissue architecture while maintaining culture simplicity through spontaneous self-organization of cells in suspension.
2Productivity
If feeder cells are used in the culture medium, then cell growth is supported, but the production cost increases due to additional components
Solution Approach 1:
The patent removes feeder cells from the culture system, achieving feeder-free suspension culture. This extraction eliminates the need for additional feeder cell components while maintaining high productivity through optimized signaling pathway modulation (Wnt inhibition, BMP and Shh activation) that supports efficient pituitary tissue formation without extra substances.
3Manufacturing precision
If high concentration of BMP signal transduction pathway activating substance is used, then pituitary tissue differentiation is enhanced, but the production cost increases
Solution Approach 1:
The patent optimizes the concentration parameter of BMP signaling activators to achieve effective pituitary tissue differentiation at lower concentrations. By combining moderate BMP activation with Wnt pathway inhibition and Shh pathway activation, the system achieves high manufacturing precision while reducing the quantity of expensive recombinant proteins required.
Solution Approach 2:
The patent creates a composite signaling environment by combining multiple pathway modulators (Wnt inhibitors, BMP activators, and Shh activators) rather than relying on high concentrations of a single substance. This composite approach achieves enhanced pituitary tissue differentiation through synergistic effects while reducing overall protein requirements and production costs.
Data Source
AI summary
The present invention aims to provide a method for efficiently producing a cell mass containing pituitary tissue from pluripotent stem cells. A method for producing a cell mass containing pituitary tissue, including the following steps (1) and (2):(1) a first step of suspension-culturing pluripotent stem cells to form a cell aggregate in the presence of a Wnt signal transduction pathway inhibiting substance,(2) a second step of suspension-culturing the aggregate obtained in the first step in the presence of a BMP signal transduction pathway activating substance and a Sonic hedgehog signal transduction pathway activating substance, thereby obtaining a cell mass comprising pituitary tissue.